BGC
BSX icon

Beutel, Goodman & Co’s Boston Scientific BSX Stock Holding History

Beutel, Goodman & Co’s Portfolio BSX Stock Details BSX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q4 		– Sell
-785
Closed -$65K – 87
2024
Q3 		$65K Buy
+785
New +$61.9K ﹤0.01% 80

Other funds holding BSX

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Beutel, Goodman & Co's BSX Position: Q4 2024 in Review

Beutel, Goodman & Co sold out of Boston Scientific (BSX) in Q4 2024, closing a stake of 785 shares — an estimated $65K sold.

Beutel, Goodman & Co first reported a position in BSX in Q3 2024 and held it in 1 quarter. The position peaked at $65K in Q3 2024. 1,512 funds tracked by Wall St. Rank hold BSX as of Q4 2024.

  • Beutel, Goodman & Co reported no remaining Boston Scientific position as of Q4 2024 after selling out during the quarter.
  • Beutel, Goodman & Co sold 785 Boston Scientific shares in Q4 2024, an estimated $65K.
  • Beutel, Goodman & Co first reported a position in Boston Scientific in Q3 2024 and held it in 1 quarter.
  • Beutel, Goodman & Co's Boston Scientific position peaked at $65K in Q3 2024.
  • 1,512 funds tracked by Wall St. Rank held Boston Scientific as of Q4 2024.

Based on Beutel, Goodman & Co's 13F filing for Q4 2024, filed 12 Feb 2025.